Accuray gets FDA nod for breast cancer treatment on Radixact

Accuray (Nasdaq:ARAY) announced that the FDA granted 510(k) clearance to its VitalHold breast package on the Radixact system.

Related Keywords

Accuray Radixact , ,Radixact System ,Accuray President ,Cecilia De Leeuw ,